8-K current report · filed May 8, 2026

Bristol Myers Squibb (BMY) 8-K Current Report: May 8, 2026

Short answer

Bristol Myers Squibb (BMY) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All 11 director nominees elected through the 2027 annual meeting, preserving board continuity.

Bristol Myers Squibb 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All 11 director nominees elected through the 2027 annual meeting, preserving board continuity
  • Executive compensation approved with 1.459B votes for and 72.5M against
  • 2026 stock award and incentive plan approved with 1.471B votes for
  • Deloitte & Touche LLP ratified as 2026 independent auditor with 1.706B votes for
  • Independent-chair proposal rejected, 1.109B votes against versus 422.1M for

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Bristol Myers Squibb 8-K filings

Get the next BMY 8-K as it lands

Follow BMY for push alerts, or ask the research agent what this filing means.